Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PowerShares Golden Dragon China Portfolio (PGJ)

26.91
Delayed Data
As of Aug 28
 -0.22 / -0.81%
Today’s Change
23.00
Today|||52-Week Range
36.36
-3.38%
Year-to-Date

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the NASDAQ Golden Dragon China Index. The fund generally will invest at least 90% of its total assets in equity securities of companies deriving a majority of their revenues from the People's Republic of China and that comprise the underlying index. The underlying index is composed of securities of U.S. exchange-listed companies that are headquartered or incorporated in the People's Republic of China. It is non-diversified.

No recent news for PowerShares Golden Dragon China Portfolio.

Performance

1 month-19.13% 3 years+12.95%
3 months-27.20% 5 years+3.25%
1 year-22.81% Since inception+6.63%
Data through 08/28/2015

Quote Details

Previous close$27.13
Open day’s range26.79 – 27.24
Net asset value (NAV)25.58 (08/25/2015)
Daily volume31,975
Average volume (3 months)67,405
Data as of 3:59pm ET, 08/28/2015

Peer Comparisonvs. China region ETFs

 PGJCategory
Performance 5-yr return+3.25%+7.28%
Expense Gross exp ratio0.70%0.68%
Risk 5 year sharpe ratio0.370.27
Net assets$193.7M$560.9M
Average market cap$8.0B$31.9B
Average P/E20.010.8
Dividend / Share--0.37%

Competitors

EWH iShares MSCI Hong Kong ETF
EWT iShares MSCI Taiwan ETF
FHK First Trust Hong Kong AlphaDEX® Fund

Holdings

Top 5 Sectors
Portfolio weighting
Telecommunication 27.14%
Energy 21.45%
Business service 9.78%
Industrial materials 9.64%
Hardware 5.77%
Top 10 Holdings
Portfolio weighting
NTES NetEase, Inc8.63%
JD JD.com8.63%
CTRP Ctrip.Com International Ltd7.89%
BIDU Baidu7.70%
VIPS Vipshop Holdings Ltd6.78%
QIHU Qihoo 360 Technology Co Ltd5.24%
CHL China Mobile4.35%
EDU New Oriental Education & Technology Group Inc2.70%
CBPO China Biologic Products Inc2.61%
WX WuXi PharmaTech (Cayman) Inc2.57%

Partner Offers